<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01092221</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-10-7724-MW-CTIL</org_study_id>
    <nct_id>NCT01092221</nct_id>
  </id_info>
  <brief_title>Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode</brief_title>
  <official_title>Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to evaluate the efficacy of allopurinol, compared to placebo,
      as add-on to mood stabilizers and/or antipsychotic in the treatment of patients with bipolar
      disorder, in a manic episode.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An emerging body of evidence supports a role for dysfunctional purinergic related
      neurotransmission in mood disorders [1, 2]. Adenosine agonists have been shown to have
      properties similar to those of dopamine antagonists and there is a well characterized
      antagonistic interaction between adenosine and dopamine receptors in the ventral striatum.
      Increased adenosynergic transmission has been demonstrated to reduce the affinity of dopamine
      agonists for dopamine receptors. It has been theorized that adenosine may exert some of its
      antipsychotic effects through modulation of glutamatergic transmission.

      Two double-blind, randomized, add-on, placebo-controlled trials comparing allopurinol and
      placebo in acute mania have showed statistically significant greater improvements in YMRS
      scores in the allopurinol vs. placebo groups. These empiric data, together with the
      theoretical and basic science background cited, provide the impetus for this proposed study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1) Change from baseline to day 42 in the YMRS</measure>
    <time_frame>from baseline to day 42</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2) Change from baseline to day 42 in the CGI-BP scale.</measure>
    <time_frame>from baseline to day 42</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1) Change from baseline to day 14 in the YMRS</measure>
    <time_frame>from baseline to day 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2) Change from baseline to day 14 in the CGI-BP scale.</measure>
    <time_frame>from baseline to day 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3) Change in the PANSS activation subscale score (total score of 6 PANSS items: Hostility, poor impulse control, excitement, uncooperativeness, poor rapport, and tension) from baseline to final assessment (Day 42).</measure>
    <time_frame>from baseline to day 42</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4) Rates of discontinuation in the allopurinol group compared to the placebo group</measure>
    <time_frame>during the study period (42 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Mania</condition>
  <arm_group>
    <arm_group_label>Allopurinol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Allopurinol</intervention_name>
    <description>Allopurinol 1 capsule 300 mg, BID</description>
    <arm_group_label>Allopurinol</arm_group_label>
    <other_name>Alloril, Zylol, Zyloric</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo 1 capsule, 300 mg, BID</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female, 18-65 years of age, inclusive

          2. Only females who are abstinent or practicing an established method of birth control
             (oral contraceptive tablets, hormonal implant device, hormone patch, injectable
             contraceptive, intrauterine device [IUD]) can be included in the trial.

          3. Willing and able to provide informed consent, after the nature of the study has been
             fully explained

          4. Current DSM-IV-TR diagnosis of bipolar I disorder with the current episode manic
             (296.4x) or mixed (296.6x), as confirmed by the Modified Structured Clinical Interview
             for DSM-IV (SCID). In order to ensure that this is an acute manic episode, we will
             verify that the current manic episode was preceded by a period of euthymia or
             depression. If inpatients, subjects will be included only up to 14 days after
             admission. Subjects with psychotic features will be included in the study.

          5. YMRS&gt; 17

          6. Patients receiving one or multiple mood stabilizers, and/or one or more
             anti-psychotics.

          7. Inpatients or outpatients.

        Exclusion Criteria:

          1. Unwilling or unable, in the opinion of the Investigator, to comply with study
             instructions

          2. Pregnant or breast-feeding

          3. Unstable medical disease (malignancy, poorly controlled diabetes, active ischemic
             cardiac disease, or cardiomyopathy, serious pulmonary disease, kidney disease,
             impaired liver functioning).

          4. Currently taking any of the following medications: warfarin, amoxicilline,
             ampicilline, theophylline, or mycophenolate mofetil.

          5. Likely allergy or sensitivity to Allopurinol

          6. At significant risk of committing suicide, or in the opinion of the Investigator,
             currently is at imminent risk of suicide or harming others.

          7. Suffers from a significant Substance Dependence disorder based on DSM-IV criteria
             within the 3 months prior to Screening, or is deemed by the Investigator to have a
             high risk of substance use during the study. Patients with a history of recreational
             use of cannabinoids or alcohol, and/or patients who smoke cigarettes can be included.

          8. Concurrent delirium, mental retardation, drug-induced psychosis, or history of brain
             trauma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Weiser</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beer-Yaakov Mental Health Center</name>
      <address>
        <city>Beer-Yaakov</city>
        <zip>70350</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat-Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lev Hasharon Mental Health Center</name>
      <address>
        <city>Zur-Moshe</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean, de Urgenta,</name>
      <address>
        <city>Cluj-Napoca,</city>
        <state>Cluj-Napoca</state>
        <zip>400012</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jebel</name>
      <address>
        <city>Timis</city>
        <state>Jebel Timis</state>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, sectia 14</name>
      <address>
        <city>Berceni st., 10-12, Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, sectia 10</name>
      <address>
        <city>Berceni st., 10-12, sector 4, Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic, sectia 8</name>
      <address>
        <city>Berceni st., sector 4 Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Psihiatrie, Titan</name>
      <address>
        <city>Bld Nicolae Grigorescu, no. 41, Sector 3,</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Psihiatrie, si Neurologie, Brasov</name>
      <address>
        <city>Brasov</city>
        <zip>500123</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie &quot;Prof.Al. Obregia&quot; Sectia 11</name>
      <address>
        <city>Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie &quot;Prof.Al. Obregia&quot; Sectia 12</name>
      <address>
        <city>Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie &quot;Prof.Al. Obregia&quot; Sectia 1</name>
      <address>
        <city>Bucharest</city>
        <zip>041902</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie &quot;Prof.Al. Obregia&quot; Sectia 3</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sp. Judetean</name>
      <address>
        <city>Focsani</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sp de Psihiatrie Galati</name>
      <address>
        <city>Galati</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, &quot;Socola&quot;,</name>
      <address>
        <city>Iasi</city>
        <zip>700282</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, Socola</name>
      <address>
        <city>Iasi</city>
        <zip>700282</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean De Urgenta, Clinica Psihiatrie</name>
      <address>
        <city>Octavian Goga st, 17, Arad</city>
        <zip>310022</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Psihiatrie, &quot;Ghe. Preda&quot; Sibiu</name>
      <address>
        <city>Sibiu</city>
        <zip>550245</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Psihiatrie Botosani</name>
      <address>
        <city>Str. I.C.Bratianu Nr. 116, Botosani</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean, Sectia Clinica Psihiatrie</name>
      <address>
        <city>Str. Victor Babes, nr. 43, Cluj Napoca</city>
        <zip>400012</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul de Psihiatrie si Neurologie</name>
      <address>
        <city>Str.Mihai Eminescu, Nr.18, Brasov</city>
        <zip>500079</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Urgenta Clinica &quot;E. Pamfil&quot;</name>
      <address>
        <city>Timisoara</city>
        <zip>300182</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>Romania</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2010</study_first_submitted>
  <study_first_submitted_qc>March 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2010</study_first_posted>
  <last_update_submitted>May 6, 2012</last_update_submitted>
  <last_update_submitted_qc>May 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mania, allopurinol, add-on treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antipsychotic Agents</mesh_term>
    <mesh_term>Allopurinol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

